4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rallybio Corporation (RLYB) operates in the Biotechnology industry and is headquartered in New Haven, United States with about 9 employees. Its market capitalization is roughly $92 million. In the fiscal year ended 2025-12-31, RLYB reported $1M in revenue and ($9M) in net income.
Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
Interactive charts & full statements → Open the RLYB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $0M | $0M | — |
| Operating Income (EBIT) | ($33M) | ($60M) | ($79M) | ($68M) | — |
| Net Income | ($9M) | ($58M) | ($75M) | ($67M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($6M) | ($7M) | ($10M) | ($10M) | — |
| Net Income | ($8M) | ($6M) | $16M | ($10M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $62M | $68M | $116M | $180M | — |
| Total Liabilities | $4M | $6M | $9M | $11M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RLYB viewer.
About TickerBase · Data methodology & sources